Molecular Partners (NASDAQ:MOLN) hosted a webcast to discuss clinical imaging and dosimetry data for MP0712, its ...

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for ...

We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. The fifteenth stock that takes place on our ...

Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission. The new molecule acts during three phases of the disease cycle, ...

Hippocampi- targeted AAV-delivered BDNF gene therapy improves cognitive impairments in Alzheimer’s disease Alzheimer’s ...

A pilot study detected Bartonella, Babesia or both in blood from almost half of people with long-term fatigue and ...

Quantum computing technology is complex, getting off the ground and maturing. There is promise of things to come. potentially changing the computing paradigm.

NanoMosaic's technology is designed to support upstream and downstream process development, quality control, and release testing.

A new approach to antimalarial development, aided by high-throughput screening, could help to overcome resistance.